Gemfibromax en es it fr

Gemfibromax Brand names, Gemfibromax Analogs

Gemfibromax Brand Names Mixture

  • No information avaliable

Gemfibromax Chemical_Formula


Gemfibromax RX_link

Gemfibromax fda sheet

Gemfibromax FDA

Gemfibromax msds (material safety sheet)

Gemfibromax Synthesis Reference

P. L. CREGER, U.S. Pat. 3,674,836 (1972)

Gemfibromax Molecular Weight

250.333 g/mol

Gemfibromax Melting Point

61-63 oC

Gemfibromax H2O Solubility

10 mg/mL (in base)

Gemfibromax State


Gemfibromax LogP


Gemfibromax Dosage Forms

Tablets; Capsules

Gemfibromax Indication

For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.

Gemfibromax Pharmacology

Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).

Gemfibromax Absorption

Well absorbed from gastrointestinal tract (within 1-2 hours).

Gemfibromax side effects and Toxicity

Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.

Gemfibromax Patient Information

Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.

Gemfibromax Organisms Affected

Humans and other mammals